The role of high-flow nasal therapy in bronchiectasis: a post hoc analysis
- PMID: 33585655
- PMCID: PMC7869600
- DOI: 10.1183/23120541.00711-2020
The role of high-flow nasal therapy in bronchiectasis: a post hoc analysis
Abstract
High-flow nasal therapy significantly reduces exacerbation rates and improves quality of life in patients with stable bronchiectasis. High-flow nasal therapy is therefore a potential treatment option for patients with bronchiectasis. https://bit.ly/2JFXuQc.
Copyright ©ERS 2021.
Conflict of interest statement
Conflict of interest: W.R. Good has nothing to disclose. Conflict of interest: J. Garrett has nothing to disclose. Conflict of interest: H.U.P. Hockey reports their work for the current study was performed under contract for Fisher & Paykel Healthcare Limited. Conflict of interest: L. Jayaram has nothing to disclose. Conflict of interest: C. Wong has nothing to disclose. Conflict of interest: H. Rea has nothing to disclose.
References
-
- Boaventura R, Shoemark A, Chalmers J. Pathophysiology In: Chalmers J, Polverino E, Aliberti S, eds. Bronchiectasis (ERS Monograph). Sheffield, European Respiratory Society, 2018; pp. 8–28.
LinkOut - more resources
Full Text Sources